Details for New Drug Application (NDA): 090181
✉ Email this page to a colleague
NDA 090181 describes IFOSFAMIDE, which is a drug marketed by Fresenius Kabi Usa, Hikma, Meitheal, Rising, and Teva Pharms Usa, and is included in six NDAs. It is available from two suppliers. Additional details are available on the IFOSFAMIDE profile page.
The generic ingredient in IFOSFAMIDE is ifosfamide; mesna. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ifosfamide; mesna profile page.
The generic ingredient in IFOSFAMIDE is ifosfamide; mesna. There are five drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the ifosfamide; mesna profile page.
Summary for 090181
| Tradename: | IFOSFAMIDE |
| Applicant: | Fresenius Kabi Usa |
| Ingredient: | ifosfamide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 090181
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/20ML (50MG/ML) | ||||
| Approval Date: | Sep 22, 2009 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 3GM/60ML (50MG/ML) | ||||
| Approval Date: | Sep 22, 2009 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
